PriceTargets.com logo

CochLear - CHEOY Stock Price Target and Predictions

  • Consensus Rating: Moderate Buy
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 0 Buy Ratings
  • 2 Strong Buy Ratings
$90.17 As of 12/4/2025 04:58 PM ET
▼ -0.78 (-0.86%)

This chart shows the closing price for CHEOY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New CochLear Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CHEOY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CHEOY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 5 analysts offering 12 month price targets for CochLear in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $90.17.

This chart shows the closing price for CHEOY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Moderate Buy

The current consensus among 5 contributing investment analysts is to moderate buy stock in CochLear. This rating has held steady since June 2025, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
12/9/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
6/7/2025
  • 1 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
9/5/2025
  • 2 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
11/4/2025
  • 2 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 2 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/7/2025Canaccord Genuity GroupUpgradeHold ➝ Strong-Buy
9/18/2025CitigroupDowngradeNeutral
8/11/2025Zacks ResearchUpgradeHold
6/18/2025UBS GroupUpgradeHold ➝ Strong-Buy
1/16/2025The Goldman Sachs GroupInitiated CoverageNeutral
8/16/2024Royal Bank Of CanadaUpgradeHold
9/5/2023Morgan StanleyDowngradeEqual Weight ➝ Underweight
5/12/2023Sanford C. BernsteinInitiated CoverageMarket Perform
2/15/2023Morgan StanleyUpgradeUnderweight ➝ Equal Weight
8/22/2022CitigroupDowngradeBuy ➝ Neutral
2/22/2022Morgan StanleyUpgradeUnderweight ➝ Equal Weight
2/22/2022The Goldman Sachs GroupUpgradeSell ➝ Buy
1/24/2022Credit Suisse GroupUpgradeNeutral ➝ Outperform
1/18/2022MacquarieDowngradeOutperform ➝ Neutral
10/1/2021CitigroupUpgradeSell ➝ Neutral
9/29/2021Morgan StanleyDowngradeEqual Weight ➝ Underweight
2/22/2021CitigroupDowngradeNeutral ➝ Sell
1/21/2021CitigroupUpgradeSell ➝ Neutral
(Data available from 12/4/2020 forward)

News Sentiment Rating

0.95 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 1 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 3 very positive mentions
  • 5 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
9/5/2025
  • 2 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/5/2025
  • 2 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
11/4/2025
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

CochLear logo
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Read More

Today's Range

Now: $90.17
Low: $89.99
High: $90.41

50 Day Range

MA: $91.99
Low: $85.66
High: $97.13

52 Week Range

Now: $90.17
Low: $74.76
High: $105.60

Volume

7,076 shs

Average Volume

18,065 shs

Market Capitalization

$11.79 billion

P/E Ratio

N/A

Dividend Yield

1.37%

Beta

0.99

Frequently Asked Questions

What sell-side analysts currently cover shares of CochLear?

The following equities research analysts have issued stock ratings on CochLear in the last year: Canaccord Genuity Group Inc., Citigroup Inc., The Goldman Sachs Group, Inc., UBS Group AG, and Zacks Research.
View the latest analyst ratings for CHEOY.

What is the current price target for CochLear?

0 Wall Street analysts have set twelve-month price targets for CochLear in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for CochLear in the next year.
View the latest price targets for CHEOY.

What is the current consensus analyst rating for CochLear?

CochLear currently has 3 hold ratings and 2 strong buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Moderate Buy."
View the latest ratings for CHEOY.

What other companies compete with CochLear?

Other companies that are similar to CochLear include Natera, Labcorp, Medpace, Icon and Solventum. Learn More about companies similar to CochLear.

How do I contact CochLear's investor relations team?

CochLear's physical mailing address is 1 University Avenue, Sydney, New South Wales 2109. The company's listed phone number is (129) 428-6555. The official website for CochLear is www.cochlear.com. Learn More about contacing CochLear investor relations.